| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neuroblastoma | 30 | 2024 | 396 | 3.450 |
Why?
|
| Osteonectin | 8 | 2016 | 22 | 2.370 |
Why?
|
| Neovascularization, Pathologic | 12 | 2011 | 353 | 1.070 |
Why?
|
| Cell Proliferation | 13 | 2024 | 1741 | 0.750 |
Why?
|
| Gene Expression Regulation, Neoplastic | 15 | 2024 | 1338 | 0.730 |
Why?
|
| Extracellular Matrix | 3 | 2011 | 256 | 0.640 |
Why?
|
| DNA Methylation | 11 | 2019 | 697 | 0.600 |
Why?
|
| Naphthyridines | 1 | 2019 | 27 | 0.580 |
Why?
|
| Angiogenesis Inhibitors | 4 | 2011 | 291 | 0.570 |
Why?
|
| Cell-Free Nucleic Acids | 3 | 2024 | 95 | 0.510 |
Why?
|
| Serum Albumin, Bovine | 1 | 2016 | 47 | 0.500 |
Why?
|
| Palmitic Acid | 1 | 2016 | 29 | 0.500 |
Why?
|
| Lipid Metabolism | 1 | 2016 | 214 | 0.450 |
Why?
|
| Biomarkers, Tumor | 3 | 2024 | 1660 | 0.430 |
Why?
|
| Cell Line, Tumor | 16 | 2024 | 2755 | 0.420 |
Why?
|
| Mice, Nude | 13 | 2018 | 824 | 0.390 |
Why?
|
| Schwann Cells | 4 | 2009 | 34 | 0.380 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2011 | 132 | 0.330 |
Why?
|
| Molecular Chaperones | 1 | 2011 | 125 | 0.330 |
Why?
|
| 5-Methylcytosine | 2 | 2024 | 121 | 0.330 |
Why?
|
| Fibroblasts | 3 | 2011 | 756 | 0.330 |
Why?
|
| Mice | 18 | 2024 | 12269 | 0.330 |
Why?
|
| Cell Movement | 7 | 2016 | 809 | 0.310 |
Why?
|
| Pancreatic Ducts | 2 | 1999 | 29 | 0.310 |
Why?
|
| Membrane Proteins | 3 | 2000 | 1264 | 0.290 |
Why?
|
| Animals | 22 | 2024 | 28155 | 0.270 |
Why?
|
| Cell Differentiation | 5 | 2024 | 1621 | 0.260 |
Why?
|
| Stromal Cells | 4 | 2009 | 151 | 0.260 |
Why?
|
| Promoter Regions, Genetic | 7 | 2012 | 962 | 0.220 |
Why?
|
| Nervous System Neoplasms | 1 | 2003 | 10 | 0.200 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2016 | 691 | 0.200 |
Why?
|
| Pancreatic Neoplasms | 2 | 1999 | 715 | 0.200 |
Why?
|
| Humans | 38 | 2024 | 93515 | 0.200 |
Why?
|
| Adenocarcinoma | 2 | 2001 | 1173 | 0.190 |
Why?
|
| Molecular Sequence Data | 6 | 2009 | 2910 | 0.190 |
Why?
|
| Methyltransferases | 1 | 2024 | 213 | 0.190 |
Why?
|
| Peptide Fragments | 1 | 2004 | 470 | 0.190 |
Why?
|
| Tumor Cells, Cultured | 6 | 2007 | 1028 | 0.190 |
Why?
|
| Valproic Acid | 3 | 2012 | 25 | 0.180 |
Why?
|
| Heterografts | 2 | 2019 | 116 | 0.180 |
Why?
|
| Neoplasms, Second Primary | 1 | 2023 | 245 | 0.170 |
Why?
|
| Xenograft Model Antitumor Assays | 5 | 2012 | 526 | 0.170 |
Why?
|
| Receptors, Androgen | 1 | 2001 | 119 | 0.160 |
Why?
|
| Apoptosis | 4 | 2019 | 1721 | 0.160 |
Why?
|
| Transfection | 5 | 2010 | 880 | 0.150 |
Why?
|
| Prognosis | 7 | 2024 | 3911 | 0.150 |
Why?
|
| Azacitidine | 4 | 2018 | 149 | 0.150 |
Why?
|
| NIH 3T3 Cells | 2 | 2011 | 111 | 0.150 |
Why?
|
| Epigenomics | 1 | 2019 | 109 | 0.150 |
Why?
|
| Antineoplastic Agents | 5 | 2012 | 2303 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2018 | 50 | 0.140 |
Why?
|
| Inflammation | 1 | 2024 | 1050 | 0.140 |
Why?
|
| Amino Acid Sequence | 4 | 2009 | 2012 | 0.140 |
Why?
|
| T-Lymphocytes | 1 | 2024 | 1275 | 0.130 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 2 | 2018 | 61 | 0.130 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2016 | 70 | 0.120 |
Why?
|
| Infant | 7 | 2024 | 3220 | 0.120 |
Why?
|
| Tissue Fixation | 1 | 2016 | 39 | 0.120 |
Why?
|
| Zonula Occludens-2 Protein | 3 | 2000 | 11 | 0.120 |
Why?
|
| Formaldehyde | 1 | 2016 | 51 | 0.120 |
Why?
|
| Paraffin Embedding | 1 | 2016 | 77 | 0.120 |
Why?
|
| Cell Hypoxia | 1 | 2016 | 187 | 0.120 |
Why?
|
| Epigenesis, Genetic | 5 | 2013 | 555 | 0.110 |
Why?
|
| Disease Progression | 2 | 2010 | 1531 | 0.110 |
Why?
|
| Neoplasms | 1 | 2009 | 3169 | 0.110 |
Why?
|
| Cell Survival | 1 | 2016 | 1004 | 0.110 |
Why?
|
| Female | 16 | 2024 | 48702 | 0.100 |
Why?
|
| Genetic Therapy | 1 | 2016 | 366 | 0.100 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2007 | 298 | 0.100 |
Why?
|
| MicroRNAs | 1 | 2018 | 580 | 0.100 |
Why?
|
| Histocompatibility Antigens | 1 | 2013 | 37 | 0.100 |
Why?
|
| Endothelial Cells | 3 | 2010 | 477 | 0.090 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2010 | 308 | 0.090 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2013 | 166 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 2 | 2011 | 436 | 0.090 |
Why?
|
| Caspase 8 | 2 | 2013 | 32 | 0.090 |
Why?
|
| Intracellular Space | 1 | 2011 | 38 | 0.090 |
Why?
|
| Mice, 129 Strain | 1 | 2011 | 56 | 0.090 |
Why?
|
| Benzenesulfonates | 1 | 2011 | 49 | 0.090 |
Why?
|
| Endothelium, Vascular | 2 | 2004 | 436 | 0.090 |
Why?
|
| Hypoxia | 1 | 2016 | 675 | 0.090 |
Why?
|
| Extracellular Space | 1 | 2011 | 88 | 0.090 |
Why?
|
| Child | 5 | 2024 | 7355 | 0.080 |
Why?
|
| MAP Kinase Signaling System | 1 | 2011 | 200 | 0.080 |
Why?
|
| Quinoxalines | 1 | 2011 | 51 | 0.080 |
Why?
|
| Genomics | 1 | 2016 | 848 | 0.080 |
Why?
|
| Histones | 3 | 2024 | 361 | 0.080 |
Why?
|
| Fibroblast Growth Factor 2 | 2 | 2007 | 57 | 0.080 |
Why?
|
| Prostatic Neoplasms | 1 | 2001 | 1775 | 0.080 |
Why?
|
| Protein Transport | 1 | 2011 | 438 | 0.080 |
Why?
|
| Pyridines | 1 | 2011 | 303 | 0.080 |
Why?
|
| Gene Silencing | 3 | 2004 | 177 | 0.080 |
Why?
|
| Collagen | 1 | 2011 | 304 | 0.080 |
Why?
|
| Models, Biological | 1 | 2016 | 1768 | 0.080 |
Why?
|
| MAP Kinase Kinase 5 | 1 | 2009 | 12 | 0.080 |
Why?
|
| rap1 GTP-Binding Proteins | 1 | 2009 | 10 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2009 | 21 | 0.080 |
Why?
|
| Thrombospondins | 1 | 2009 | 15 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2001 | 887 | 0.080 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2012 | 156 | 0.070 |
Why?
|
| HEK293 Cells | 1 | 2011 | 696 | 0.070 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2009 | 75 | 0.070 |
Why?
|
| Child, Preschool | 3 | 2024 | 3829 | 0.070 |
Why?
|
| Sequence Alignment | 1 | 2009 | 352 | 0.070 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2009 | 192 | 0.070 |
Why?
|
| Thrombospondin 1 | 2 | 2010 | 22 | 0.070 |
Why?
|
| Neoplasm Metastasis | 3 | 2019 | 1061 | 0.070 |
Why?
|
| Transcription, Genetic | 3 | 2003 | 1117 | 0.070 |
Why?
|
| Receptors, Cell Surface | 1 | 2009 | 292 | 0.070 |
Why?
|
| Base Sequence | 3 | 1999 | 2220 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2011 | 603 | 0.070 |
Why?
|
| Male | 10 | 2024 | 44557 | 0.070 |
Why?
|
| Tumor Necrosis Factor Decoy Receptors | 1 | 2007 | 4 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2016 | 876 | 0.070 |
Why?
|
| Transplantation, Heterologous | 2 | 2006 | 371 | 0.070 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2009 | 457 | 0.060 |
Why?
|
| Cell Division | 3 | 2003 | 693 | 0.060 |
Why?
|
| Neoplasm Transplantation | 4 | 2011 | 399 | 0.060 |
Why?
|
| Calcium | 1 | 2011 | 1176 | 0.060 |
Why?
|
| Peptides | 1 | 2010 | 656 | 0.060 |
Why?
|
| Mice, Knockout | 1 | 2011 | 2121 | 0.060 |
Why?
|
| Cells, Cultured | 1 | 2011 | 2850 | 0.060 |
Why?
|
| Methylation | 1 | 2007 | 288 | 0.060 |
Why?
|
| Blotting, Western | 3 | 2009 | 784 | 0.060 |
Why?
|
| Oligopeptides | 1 | 2007 | 191 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2009 | 2495 | 0.060 |
Why?
|
| Infant, Newborn | 3 | 2019 | 2479 | 0.060 |
Why?
|
| Epidermal Growth Factor | 1 | 2004 | 115 | 0.050 |
Why?
|
| DNA, Neoplasm | 2 | 2004 | 266 | 0.050 |
Why?
|
| Conserved Sequence | 1 | 2004 | 209 | 0.050 |
Why?
|
| Cell Cycle | 3 | 2011 | 515 | 0.050 |
Why?
|
| Immunohistochemistry | 3 | 2007 | 1799 | 0.050 |
Why?
|
| Heat-Shock Proteins | 1 | 2004 | 178 | 0.050 |
Why?
|
| Cytokines | 1 | 2007 | 863 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2004 | 729 | 0.050 |
Why?
|
| Introns | 2 | 2000 | 300 | 0.050 |
Why?
|
| Protein Folding | 1 | 2004 | 292 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2009 | 3502 | 0.050 |
Why?
|
| Exons | 2 | 2000 | 450 | 0.040 |
Why?
|
| Prostaglandin D2 | 1 | 2001 | 28 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2004 | 537 | 0.040 |
Why?
|
| Acetylation | 2 | 2012 | 149 | 0.040 |
Why?
|
| Thiazolidinediones | 1 | 2001 | 77 | 0.040 |
Why?
|
| Urothelium | 1 | 2001 | 67 | 0.040 |
Why?
|
| Adenosine | 1 | 2024 | 275 | 0.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2001 | 123 | 0.040 |
Why?
|
| Kidney | 1 | 2006 | 1111 | 0.040 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2012 | 107 | 0.040 |
Why?
|
| Kidney Neoplasms | 1 | 2006 | 546 | 0.040 |
Why?
|
| Androgens | 1 | 2001 | 162 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 1999 | 54 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2000 | 295 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2001 | 543 | 0.040 |
Why?
|
| Gene Expression Profiling | 2 | 2016 | 1518 | 0.040 |
Why?
|
| Blotting, Northern | 1 | 1999 | 244 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 1999 | 119 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 1999 | 129 | 0.040 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2018 | 20 | 0.040 |
Why?
|
| Multigene Family | 1 | 1999 | 203 | 0.040 |
Why?
|
| Enzyme Inhibitors | 2 | 2013 | 641 | 0.040 |
Why?
|
| Cricetinae | 1 | 1999 | 532 | 0.040 |
Why?
|
| MCF-7 Cells | 1 | 2018 | 120 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2018 | 162 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2018 | 254 | 0.030 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2001 | 378 | 0.030 |
Why?
|
| RNA, Long Noncoding | 1 | 2018 | 129 | 0.030 |
Why?
|
| Transcription Factors | 2 | 2004 | 1691 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2001 | 2026 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2023 | 1448 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2007 | 2544 | 0.030 |
Why?
|
| Databases, Nucleic Acid | 1 | 2016 | 44 | 0.030 |
Why?
|
| Neurons | 1 | 2005 | 1582 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 2010 | 894 | 0.030 |
Why?
|
| Chromosome Aberrations | 1 | 2016 | 350 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 889 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2014 | 3054 | 0.030 |
Why?
|
| Gene Expression | 2 | 2012 | 1301 | 0.020 |
Why?
|
| Azepines | 1 | 2013 | 28 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2016 | 1170 | 0.020 |
Why?
|
| N-Myc Proto-Oncogene Protein | 1 | 2013 | 40 | 0.020 |
Why?
|
| Adult | 3 | 2019 | 27918 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2013 | 85 | 0.020 |
Why?
|
| Adolescent | 2 | 2019 | 9606 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2013 | 162 | 0.020 |
Why?
|
| Computational Biology | 1 | 2016 | 578 | 0.020 |
Why?
|
| Oncogene Proteins | 1 | 2013 | 65 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2014 | 391 | 0.020 |
Why?
|
| G1 Phase | 1 | 2012 | 64 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2010 | 1914 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2018 | 776 | 0.020 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2012 | 68 | 0.020 |
Why?
|
| Doxorubicin | 1 | 2013 | 284 | 0.020 |
Why?
|
| Quinazolines | 1 | 2013 | 211 | 0.020 |
Why?
|
| Histone Deacetylases | 1 | 2012 | 86 | 0.020 |
Why?
|
| Tretinoin | 1 | 2012 | 129 | 0.020 |
Why?
|
| Niacinamide | 1 | 2011 | 101 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2012 | 272 | 0.020 |
Why?
|
| Phenylurea Compounds | 1 | 2011 | 97 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2016 | 2017 | 0.020 |
Why?
|
| Transcriptome | 1 | 2016 | 762 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 2715 | 0.020 |
Why?
|
| DNA Modification Methylases | 1 | 2010 | 32 | 0.020 |
Why?
|
| Colorectal Neoplasms | 1 | 2018 | 1053 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2011 | 295 | 0.020 |
Why?
|
| Cell Shape | 1 | 2010 | 50 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2010 | 139 | 0.020 |
Why?
|
| Inhibitor of Differentiation Protein 1 | 1 | 2009 | 8 | 0.020 |
Why?
|
| Pericytes | 1 | 2009 | 14 | 0.020 |
Why?
|
| Sciatic Nerve | 1 | 2009 | 37 | 0.020 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2009 | 21 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2013 | 740 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2012 | 636 | 0.020 |
Why?
|
| Young Adult | 1 | 2019 | 6930 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2007 | 134 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2007 | 83 | 0.020 |
Why?
|
| Capillary Permeability | 1 | 2007 | 131 | 0.020 |
Why?
|
| Actins | 1 | 2009 | 467 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2011 | 9099 | 0.010 |
Why?
|
| Genotype | 1 | 2010 | 1866 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2007 | 524 | 0.010 |
Why?
|
| GAP-43 Protein | 1 | 2005 | 2 | 0.010 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2005 | 6 | 0.010 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2005 | 47 | 0.010 |
Why?
|
| Ganglioneuroma | 1 | 2004 | 9 | 0.010 |
Why?
|
| Ki-67 Antigen | 1 | 2005 | 66 | 0.010 |
Why?
|
| Helix-Loop-Helix Motifs | 1 | 2004 | 27 | 0.010 |
Why?
|
| S100 Proteins | 1 | 2005 | 51 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2005 | 122 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2004 | 60 | 0.010 |
Why?
|
| HSP47 Heat-Shock Proteins | 1 | 2004 | 3 | 0.010 |
Why?
|
| Collagen Type IV | 1 | 2004 | 28 | 0.010 |
Why?
|
| Collagen Type I | 1 | 2004 | 74 | 0.010 |
Why?
|
| HLA Antigens | 1 | 2005 | 228 | 0.010 |
Why?
|
| Phenotype | 1 | 2010 | 2544 | 0.010 |
Why?
|
| CpG Islands | 1 | 2003 | 168 | 0.010 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2004 | 244 | 0.010 |
Why?
|
| Biomarkers | 1 | 2009 | 1910 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2004 | 730 | 0.010 |
Why?
|
| Chromans | 1 | 2001 | 28 | 0.010 |
Why?
|
| Thiazoles | 1 | 2001 | 124 | 0.010 |
Why?
|
| Survival Rate | 1 | 2004 | 1948 | 0.010 |
Why?
|
| Ligands | 1 | 2001 | 476 | 0.010 |
Why?
|
| Dinucleotide Repeats | 1 | 1999 | 14 | 0.010 |
Why?
|
| Immunologic Factors | 1 | 2001 | 176 | 0.010 |
Why?
|
| Myosin-Light-Chain Kinase | 1 | 1999 | 38 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1999 | 384 | 0.010 |
Why?
|
| DNA Primers | 1 | 1999 | 531 | 0.010 |
Why?
|
| Rabbits | 1 | 1999 | 618 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 1999 | 219 | 0.010 |
Why?
|
| Cell Line | 1 | 2001 | 2464 | 0.010 |
Why?
|
| Alleles | 1 | 1999 | 1139 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 1999 | 826 | 0.010 |
Why?
|
| Aged | 1 | 2001 | 20434 | 0.000 |
Why?
|